Mild COVID-19 in ANCA-associated vasculitis treated with rituximab

Ann Rheum Dis. 2021 Jun;80(6):e99. doi: 10.1136/annrheumdis-2020-218246. Epub 2020 Aug 7.
No abstract available

Keywords: B-Lymphocytes; autoimmune diseases; rituximab.

Publication types

  • Letter

MeSH terms

  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / complications
  • Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis* / drug therapy
  • Antibodies, Antineutrophil Cytoplasmic
  • COVID-19*
  • Humans
  • Remission Induction
  • Rituximab / therapeutic use

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Rituximab